Lipid Peroxidation and Cataracts: N-Acetylcarnosine as a Therapeutic Tool to Manage Age-Related Cataracts in Human and in Canine Eyes

By Babizhayev M.A.   Deyev A.I.  

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 125-139

Adis International

Access to resources Recommend Favorite

State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases

By  

Current Clinical Pharmacology, Vol. 4, Iss. 1, 2009-01 ,pp. : 4-37

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers of Oxidative Stress and Cataract. Novel Drug Delivery Therapeutic Strategies Targeting Telomere Reduction and the Expression of Telomerase Activity in the Lens Epithelial Cells with N-Acetylcarnosine Lubricant Eye Drops: Anti-Cataract which Helps to Prevent and Treat Cataracts in the Eyes of Dogs and other Animals

By  

Current Drug Delivery, Vol. 11, Iss. 1, 2014-02 ,pp. : 24-61

Bentham Science Publishers

Access to resources Recommend Favorite

Ocular Drug Metabolism of the Bioactivating Antioxidant N-acetylcarnosine for Vision in Ophthalmic Prodrug and Codrug Design and Delivery

By Babizhayev Mark  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 10, 2008-10 ,pp. : 1071-1089

Informa Healthcare

Access to resources Recommend Favorite

Analysis of Lipid Peroxidation and Electron Microscopic Survey of Maturation Stages during Human Cataractogenesis: Pharmacokinetic Assay of Can-C™ N-Acetylcarnosine Prodrug Lubricant Eye Drops for Cataract Prevention

By Babizhayev Mark A.  

Drugs in R&D, Vol. 6, Iss. 6, 2005-01 ,pp. : 345-369

Adis International

Access to resources Recommend Favorite